Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fujitsu

- PMLiVE

Myovant’s fibroids drug clears phase 3 trial, but shares sink

Investors concerned on how it stacks up against AbbVie rival

- PMLiVE

Data regulations impeding AI use in drug research

Lack of data specialists another concern

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

Bedrock Healthcare Communications

- PMLiVE

Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity

Firm says it cuts discovery timelines by 75%

How Medisafe is using AI to improve patient adherence

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

Blue Latitude Health

Pharma iPad detailing doctors physicians

A genomics and digital-led NHS is possible – but investment in staff essential

Powerful technologies will lead to an “evolution of the patient-doctor relationship”

The AI revolution – Ben Greenberg

Four Health

- PMLiVE

AI specialist Exscientia buys Kinetic Discovery

The biophysics tech will radically improve the drug discovery paradigm, says Exscientia

Safety first: AI adoption in the healthcare sector

AI's transformative impact on healthcare

- PMLiVE

How pharma should navigate Artificial Intelligence (AI)

Developing an AI strategy that cuts through the hype

Artificial intelligence in healthcare

What are the benefits for pharma?

- PMLiVE

AI UK – one year on

Are patients still cautiously embracing new healthcare tools?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links